EHI
TNDM icon

Eagle Health Investments’s Tandem Diabetes Care TNDM Stock Holding History

Eagle Health Investments’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-320,325
Closed -$7.86M – 25
2023
Q2 		$7.86M Sell
320,325
-105,200
-25% -$3.38M 1.47% 21
2023
Q1 		$17.3M Sell
425,525
-164,975
-28% -$6.83M 3.36% 15
2022
Q4 		$26.5M Buy
590,500
+394,100
+201% +$17.8M 6.12% 8
2022
Q3 		$9.4M Buy
+196,400
New +$10.8M 2.16% 16

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Eagle Health Investments's TNDM Position: Q3 2023 in Review

Eagle Health Investments sold out of Tandem Diabetes Care (TNDM) in Q3 2023, closing a stake of 320,325 shares — an estimated $7.86M sold.

Eagle Health Investments first reported a position in TNDM in Q3 2022 and held it in 4 quarters. The position peaked at $26.5M in Q4 2022. 226 funds tracked by Wall St. Rank hold TNDM as of Q3 2023.

  • Eagle Health Investments reported no remaining Tandem Diabetes Care position as of Q3 2023 after selling out during the quarter.
  • Eagle Health Investments sold 320,325 Tandem Diabetes Care shares in Q3 2023, an estimated $7.86M.
  • Eagle Health Investments first reported a position in Tandem Diabetes Care in Q3 2022 and held it in 4 quarters.
  • Eagle Health Investments's Tandem Diabetes Care position peaked at $26.5M in Q4 2022.
  • 226 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2023.

Based on Eagle Health Investments's 13F filing for Q3 2023, filed 27 Oct 2023.